A Dutch clinical-stage biotech company
InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation drug delivery
InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation drug delivery
Total raised: $32.92M
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.02.2021 | Series B | $22.42M | - |
| 15.12.2015 | Series A | $10.5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 15.02.2021 | OostNL backs the €18.5M Series B funding round of this Dutch biotech company that’s fighting cancer | Netherlands-based InteRNA Technologies, a biopharma company that develops microRNA (miRNA)-based therapeutics for oncology, has announced the close of its Series B round with extended funding of €18.5M in total. Oncology is a branch of medi... |
| 09.02.2021 | InteRNA Technologies Extends Series B Financing Round Totaling €18.5M | InteRNA Technologies, an Utrecht, The Netherlands-based company that designs new therapies tackling cancer, closed an extended Series B financing round amounting to €18.5M in total. This Series B round was led by AurorA Science, an Italian ... |
| 15.12.2015 | InteRNA Technologies Closes US$10.5M Series A Funding | InteRNA Technologies B.V., a Nijmegen, the Netherlands–based biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, recently raised a final tranche of its Series A funding and closed it at US$10.5m... |
| 26.03.2013 | InteRNA Technologies Raises Funding | InteRNA Technologies B.V., a Nijmegen, The Netherlands-based biopharmaceutical company, closed an equity financing round of undisclosed amount. Backers included new investors the Innovation & Investment Fund Gelderland, managed by PPM O... |